Latest Health & pharmaceuticals news

8th July 2013
GSK Share Price: UK Drug Maker Looking into New Bribery Allegations
4th July 2013
Brazil – all the best of Property Investment
21st June 2013
GSK Share Price: British Drugmaker to Invest €17.5 Million in New Venture Fund
19th June 2013
AstraZeneca’s Diabetes Drug Fails to Pass Clinical Trial
12th June 2013
Pfizer Stock Price Rises on a $2.15 Billion Protonix Accord
10th June 2013
AstraZeneca’s Share Price Climbs on Pearl Therapeutics Acquisition Plan
4th June 2013
AstraZeneca Drops Experimental Rheumatoid Arthritis Treatment
29th May 2013
Can The Yuan Replace The Dollar As Reserve Currency?
28th May 2013
AstraZeneca’s Share Price Surges on Omthera Acquisition
27th May 2013
Valeant Pharmaceuticals Buying Bausch & Lomb for $8.7 Billion
24th May 2013
REIT Watch: Sabra Health Care Updates 2013 Guidance
24th May 2013
Procter & Gamble Ousts CEO McDonald and Re-Hires A.G. Lafley
13th May 2013
Irish Drugmaker Elan Agrees $1 Billion Royalty Deal With Theravance
30th April 2013
Increased Full-Year Loss Sends Ark Therapeutics’ Shares Plunging in London
30th April 2013
Lower-Than-Expected Q1 Earnings and Revenue Depress Pfizer’s Shares
30th April 2013
Avacta Group’s Revenue Drops on Slowdown in Sales of Optim Analytical Devices
26th April 2013
Colgate’s Shares Surge on 2.5 Percent Q1 Sales Growth
25th April 2013
AstraZeneca’s Share Price Marginally Down on 25 Percent Drop in Earnings
24th April 2013
GlaxoSmithKline’s Share Price Edges Up on Dividend Lift and Unchanged Full-Year Guidance
24th April 2013
AstraZeneca’s Share Price Expected to Suffer From Projected 26% Drop in Q1 Earnings
23rd April 2013
GlaxoSmithKline’s Share Price Rally Threatened by Lower Q1 Profit Forecasts
16th April 2013
Royalty Pharma Willing to Pay as Much as $7.3 Billion for Elan
11th April 2013
Roche Posts Five Percent Sales Growth in Q1 2013
2nd April 2013
Novartis Loses Key Patent Drug Case in India
1 48 49 50 51 52 53 54 55 56 57
Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.